OOIR: Observatory of International Research

Papers

(The TQCC of BMJ Open Respiratory Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Sleep apnoea is a risk factor for severe COVID-19	92
Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea	64
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals	56
Patient symptoms and experience following COVID-19: results from a UK-wide survey	52
Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA	51
Rationale for azithromycin in COVID-19: an overview of existing evidence	47
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation	45
ARTP statement on cardiopulmonary exercise testing 2021	42
Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey	39
Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery	39
Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study	37
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA₁) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung dise	32
Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trial	32
Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells	30
COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation	30
Impact of corticosteroids in hospitalised COVID-19 patients	30
Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study	30
Disease burden and quality of life of patients with chronic cough in Japan: a population-based cross-sectional survey	29
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda	28
Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort	28
Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis	28
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)	26
Working accuracy of pulse oximetry in COVID-19 patients stepping down from intensive care: a clinical evaluation	26
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries	26
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank	25

Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease	25
Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis	25
Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis	25
Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study	24
Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis	23
Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysis	23
Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19	22
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review	21
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response	21
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis	21
Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study	21
Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis	21
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design	21
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study	20
Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review	18
BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD	18
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial	18
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern	17
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial	17
¹²⁹Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome	17
Economic burden of asthma in Singapore	17
Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations—a cross-sectional study	17
Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO Study of AGEing and adult health wave 1	16
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates	16
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis	15
Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial	15
Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study	15
The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease	15
Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies	15
Cardiopulmonary function in adolescent patients with pectus excavatum or carinatum	14
Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia	14
Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts	14
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis	14
Ambient air pollution and risk of respiratory infection among adults: evidence from the multiethnic study of atherosclerosis (MESA)	14
Lung ultrasound volume sweep imaging for respiratory illness: a new horizon in expanding imaging access	14
Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies	13
Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study	13
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Aus	13
Physiological demands of singing for lung health compared with treadmill walking	13
Dance for people with chronic breathlessness: a transdisciplinary approach to intervention development	13
Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study	13
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol	12
Frailty assessment for COVID-19 follow-up: a prospective cohort study	12
Web-based survey to evaluate the prevalence of chronic and subacute cough and patient characteristics in Japan	12
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry	12
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases	12
Endotypes identified by cluster analysis in asthmatics and non-asthmatics and their clinical characteristics at follow-up: the case-control EGEA study	12
COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation	12
BTS clinical statement for the diagnosis and management of ocular tuberculosis	11
Lower geriatric nutritional risk index is associated with a higher risk of all-cause mortality in patients with chronic obstructive pulmonary disease: a cohort study from the National Health and Nutri	11

Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study	11
Effect of a home-based inspiratory muscular training programme on functional capacity in patients with chronic COVID-19 after a hospital discharge: protocol for a randomised control trial (InsCOVID tr	11
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study	11
Performance of popular pulse oximeters compared with simultaneous arterial oxygen saturation or clinical-grade pulse oximetry: a cross-sectional validation study in intensive care patients	11
Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study	11
Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia	11
Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis	11
Early experiences of the Your COVID Recovery^®digital programme for individuals with long COVID	10
Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience	10
Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia	10
Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021	10
Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience	10
Development in PaCO₂over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled	10
Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter	10
Asthma, atopy and lung function in young adults after hospitalisation for bronchiolitis in infancy: impact of virus and sex	10
Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy	10
Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database	9
Persisting breathlessness and activities reduced or ceased: a population study in older men	9
Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions	9
Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis	9
Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians	9
Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases	9
Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode	9
Trends in hospital admissions and mortality rates for asthma in Ecuador: a joinpoint regression analysis of data from 2000 to 2018	9
Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed	9
Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review	9
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer	9
Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis	8
Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework	8
Symptomatic, biochemical and radiographic recovery in patients with COVID-19	8
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance	8
Improving the early identification of COVID-19 pneumonia: a narrative review	8
Physiological tests of small airways function in diagnosing asthma: a systematic review	8
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active	8
Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics	8
Relationship ofPneumocystisantibody responses to paediatric asthma severity	8
Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study	8
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection	8
Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial	8
Inhaled corticosteroid dose is associated withPseudomonas aeruginosainfection in severe COPD	8
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy	8
‘It’s not one size fits all’: a qualitative study of patients’ and healthcare professionals’ views of self-management for bronchiectasis	8
Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort study	8
Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2–4	8
Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care (RECEIVER): the protocol for a feasibility and service adoption observational cohort study	7
Health economic analysis for the ‘CURE Project’ pilot: a hospital-based tobacco dependency treatment service in Greater Manchester	7
Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study	7
Large scale clinical trials: lessons from the COVID-19 pandemic	7
Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics	7
Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis	7
Childhood ‘bronchitis’ and respiratory outcomes in middle-age: a prospective cohort study from age 7 to 53 years	7
Acute hypoxaemic respiratory failure in a low-income country: a prospective observational study of hospital prevalence and mortality	7
Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study	7
Typical within and between person variability in non-invasive ventilator derived variables among clinically stable, long-term users	7
Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy	7
Changes in central venous to arterial carbon dioxide gap (PCO₂gap) in response to acute changes in ventilation	7
Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD	7
Effectiveness, usability and acceptability of a smart inhaler programme in patients with asthma: protocol of the multicentre, pragmatic, open-label, cluster randomised controlled ACCEPTANCE trial	7
Novel non-invasive particles in exhaled air method to explore the lining fluid of small airways—a European population-based cohort study	7
Stability in eosinophil categorisation during subsequent severe exacerbations of COPD	7
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients	7
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population	6
Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency	6
Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure	6
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis andPseudomonas aeruginosa	6
Dysfunctional breathing symptoms, functional impact and quality of life in patients with long COVID-19: a prospective case series	6
The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled	6
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy	6
The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD	6
Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey	6
COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills	6
Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts	6
Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience	6
The ‘ABC’ of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians – a systematic review	6
Defining hypoxaemia from pulse oximeter measurements of oxygen saturation in well children at low altitude in Bangladesh: an observational study	6
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis	6
Extracorporeal CO₂removal in acute exacerbation of COPD unresponsive to non-invasive ventilation	6
Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies	6
Early respiratory diagnosis: benefits of enhanced lung function assessment	6
Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study	6